American Gene Technologies Announces First Trial Participant Enrolled in Phase 1 Study of AGT103-T Against HIV

    NEXT STORY
    Capacity and Capabilities of South Africa’s Healthcare System in 2020
    PREV STORY
    Novavax to Host Conference Call for Questions Related to Third Quarter Financial and Operating Results on November 10, 2020
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    AzurRx Provides Update on MS1819 Phase II Trial

    Initial patient experience shows no safety issues MS1819 appears active, as demonstrated by CFA ...

    author_avatar
    NASDAQ Market News

    INNATE PHARMA : 2016 reference document made available (in french)

    INNATE PHARMA: 2016 REFERENCE DOCUMENT MADE AVAILABLE (IN FRENCH) Marseille, France, April 3, 2017 ...

    author_avatar
    NASDAQ Market News

    Global Blood Culture Tests Market Worth Reach USD 3,989 Million By 2025: Zion Market Research

    author_avatar
    NASDAQ Market News